Supply of Bismuth Subsalicylate (OTC Medication)

The Defense Logistics Agency, under the Department of Defense, has issued a subcontract for the procurement and delivery of three packages of Bismuth Subsalicylate, identified by NSN 6505014437607 and NDC 00904-7205-46, a non-prescription gastrointestinal medication used to treat diarrhea, nausea, and indigestion in military operational settings. The contract is classified under NAICS code 325412, indicating pharmaceutical and medicine manufacturing, and was posted on July 16, 2026, as part of ongoing efforts to maintain medical supply readiness across DOD facilities and deployed units. Delivery is expected to support logistical requirements for field medical units, with no specific place of performance designated beyond general military logistics channels. The subcontract does not include a solicitation number or set-aside designation, suggesting it may be a direct award or derived from an existing master agreement. The procurement is not tied to a specific geographic location for performance, indicating centralized distribution through DLA’s supply network. The contract's purpose is strictly logistical—ensuring adequate inventory of this essential over-the-counter medication within the military’s pharmaceutical supply chain. The official record can be accessed via the DIBBS portal using the provided link, and all fulfillment activities are coordinated under the agency’s standard procurement and inventory management protocols for non-prescription medical items.